These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32387259)
1. Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics. Cento V; Nava A; Lepera V; Torri S; Colagrossi L; Fanti D; Vismara C; Perno CF; Mazzola E J Glob Antimicrob Resist; 2020 Sep; 22():533-537. PubMed ID: 32387259 [TBL] [Abstract][Full Text] [Related]
2. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system. Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736 [TBL] [Abstract][Full Text] [Related]
3. Nontuberculous Mycobacteria under Scrutiny in the Geneva Area (2015-2020). Vongthilath-Moeung R; Plojoux J; Poncet A; Renzi G; Veziris N; Schrenzel J; Janssens JP Respiration; 2022; 101(4):367-375. PubMed ID: 34875659 [TBL] [Abstract][Full Text] [Related]
4. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline]. Wagner D; Lange C Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study. Zaheen A; Hirama T; Mehrabi M; Brode SK; Marras TK Respir Med; 2020 Jun; 167():105967. PubMed ID: 32421543 [TBL] [Abstract][Full Text] [Related]
6. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. Manfredi R; Nanetti A; Morelli S; Ferri M; Valentini R; Calza L; Chiodo F HIV Clin Trials; 2004; 5(4):206-15. PubMed ID: 15472795 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria. Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Brown-Elliott BA; Crist CJ; Mann LB; Wilson RW; Wallace RJ Antimicrob Agents Chemother; 2003 May; 47(5):1736-8. PubMed ID: 12709349 [TBL] [Abstract][Full Text] [Related]
9. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey]. Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634 [TBL] [Abstract][Full Text] [Related]
10. Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State. Ford ES; Horne DJ; Shah JA; Wallis CK; Fang FC; Hawn TR Ann Am Thorac Soc; 2017 Jul; 14(7):1129-1138. PubMed ID: 28387523 [TBL] [Abstract][Full Text] [Related]
11. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease. Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990 [TBL] [Abstract][Full Text] [Related]
13. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline]. Wagner D; Lange C Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438 [TBL] [Abstract][Full Text] [Related]
14. [Nontuberculous mycobacteria: M. marinum, M. ulcerans, M. xenopi - brief characteristics of the bacteria and diseases caused by them]. Fol M; Olek J; Kowalewicz-Kulbat M; Druszczyńska M; Rudnicka W Postepy Hig Med Dosw (Online); 2011 Sep; 65():574-83. PubMed ID: 21918261 [TBL] [Abstract][Full Text] [Related]
15. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients. Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254 [TBL] [Abstract][Full Text] [Related]
16. Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture system. Piersimoni C; Nista D; Bornigia S; Gherardi G J Clin Microbiol; 2009 Mar; 47(3):804-6. PubMed ID: 19144802 [TBL] [Abstract][Full Text] [Related]
17. Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease. Yan M; Brode SK; Marras TK Clin Chest Med; 2023 Dec; 44(4):799-813. PubMed ID: 37890917 [TBL] [Abstract][Full Text] [Related]
18. Drug Susceptibility of Non-tuberculous Strains of Ledwoń A; Napiórkowska A; Augustynowicz-Kopeć E; Szeleszczuk P Pol J Microbiol; 2018; 67(4):487-492. PubMed ID: 30550235 [TBL] [Abstract][Full Text] [Related]
19. [Distribution and drug resistance of nontuberculous Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817 [No Abstract] [Full Text] [Related]
20. In vitro sensitivity of Mycobacterium xenopi to five antibiotics. Dauendorffer JN; Laurain C; Weber M; Dailloux M Pathol Biol (Paris); 2002 Dec; 50(10):591-4. PubMed ID: 12504367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]